Aims and Scope of European Journal of Medicinal Chemistry
The European Journal of Medicinal Chemistry is a monthly peer-reviewed scientific journal covering medicinal chemistry and published by Elsevier. It was established in 1966 as Chimica Therapeutica (CODEN: CHTPBA) and obtained its current title in 1974. From 1974 to 1981 the journal was still subtitled as Chimica Therapeutica and from 1982 to 1986 the subtitle was Chimie Thérapeutique, indicating its French origin. And now it is the journal of the French Société de Chimie Thérapeutique. Less
Key Metrics
CiteScore 

11.2
H-Index 

188
Impact Factor 

5 - 10
Scite Index 

0.93 5-Year SI

SJR 

Q1Pharmacology

SNIP 

1.57
Recommended pre-submission checks
Powered by 

Topics Covered on European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry Journal Specifications
| Overview | |
| Publisher | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER |
| Language | Multi-Language |
| Frequency | Semi-monthly |
| General Details | |
| Language | Multi-Language |
| Frequency | Semi-monthly |
| Publication Start Year | 1965 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in European Journal of Medicinal Chemistry ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in European Journal of Medicinal Chemistry
Peripheral structural engineering of quinoline-malononitrile-triphenylamine (QM-TPA) core enhances Anti-tumor PDT efficacy through necroptosis.
- 5 Oct 2026
- European journal of medicinal chemistry
Structural optimization of cholesteryl ester transfer protein inhibitors: From early scaffolds to advanced clinical candidates.
- 5 Oct 2026
- European journal of medicinal chemistry
AI and pharmacophore-based screening, molecular docking, and dynamic simulation for identification of CDK6 inhibitors to combat NSCLC.
- 5 Oct 2026
- European journal of medicinal chemistry
Multi-target Triazole-Benzopyrone hybrids modulating cholinergic dysfunction, oxidative stress, and neuroinflammation through GFAP/NF-κB/APOE/NLRP3 axis in Alzheimer's disease.
- 5 Oct 2026
- European journal of medicinal chemistry
Unlocking new frontiers in AKR1B10 inhibition and future opportunities.
- 5 Oct 2026
- European journal of medicinal chemistry
New chalcogen-optimized 1,3,5-triazines as dual 5-HT6R/FAAH modulators: A versatile approach to neurodegenerative disorders.
- 5 Oct 2026
- European journal of medicinal chemistry
Peripheral structural engineering of quinoline-malononitrile-triphenylamine (QM-TPA) core enhances Anti-tumor PDT efficacy through necroptosis.
- 5 Oct 2026
- European journal of medicinal chemistry
Structural optimization of cholesteryl ester transfer protein inhibitors: From early scaffolds to advanced clinical candidates.
- 5 Oct 2026
- European journal of medicinal chemistry
AI and pharmacophore-based screening, molecular docking, and dynamic simulation for identification of CDK6 inhibitors to combat NSCLC.
- 5 Oct 2026
- European journal of medicinal chemistry
Multi-target Triazole-Benzopyrone hybrids modulating cholinergic dysfunction, oxidative stress, and neuroinflammation through GFAP/NF-κB/APOE/NLRP3 axis in Alzheimer's disease.
- 5 Oct 2026
- European journal of medicinal chemistry
Unlocking new frontiers in AKR1B10 inhibition and future opportunities.
- 5 Oct 2026
- European journal of medicinal chemistry
New chalcogen-optimized 1,3,5-triazines as dual 5-HT6R/FAAH modulators: A versatile approach to neurodegenerative disorders.
- 5 Oct 2026
- European journal of medicinal chemistry